US Nuclear (UCLE) S-1/A 19 Jul 22 IPO registration (amended) Financial data

Document And Entity Information

Document And Entity Information	3 Months Ended
	Mar. 31, 2022
Document Information Line Items
Entity Registrant Name	US NUCLEAR CORP.
Document Type	S-1/A
Amendment Flag	true
Amendment Description	This registration statement and the prospectus therein covers the registration of 28,602,600 shares of common stock (the “Shares”) in US Nuclear Corp., a Delaware corporation (the “Company,” “US Nuclear,” or “us”). Of those Shares, 17,602,600 are shares owned by Selling Shareholders (the “Selling Shareholder Shares”) and the remaining 11,000,000 shares are subject of a Common Stock Purchase Warrant between the Company and Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”).The information contained in this prospectus is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and these securities may not be sold until that registration statement becomes effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
Entity Central Index Key	0001543623
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Incorporation, State or Country Code	DE

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 65,855	$ 246,317	$ 227,304
Accounts receivable, net	81,036	163,577	255,202
Inventories	1,733,341	1,792,312	1,317,687
Prepaid expenses and other current assets	4,713	44,026	4,000
TOTAL CURRENT ASSETS	1,884,945	2,246,232	1,804,193
Property and equipment, net	8,689	9,719	5,844
Right-of-use assets			55,079
Investments	10,059	10,059	19,616
Acquisition deposit	15,000	15,000
Goodwill	570,176	570,176	570,176
TOTAL ASSETS	2,488,869	2,851,186	2,454,908
CURRENT LIABILITIES
Accounts payable	62,635	91,859	60,977
Accounts payable - related party	170,500	128,500
Accrued liabilities	639,551	587,941	96,983
Accrued compensation - officers	635,000	590,000	430,000
Customer deposit	85,751	101,342	194,311
Note payable	20,619	48,541	9,818
Note payable to shareholder	755,260	576,260	443,850
Operating lease liability			55,079
Line of credit	305,427	285,743	209,143
TOTAL CURRENT LIABILITIES	2,674,743	2,409,917	1,500,161
Note payable, net of current portion			107,587
TOTAL LIABILITIES	2,674,743	2,409,917	1,607,748
COMMITMENTS & CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized, 28,428,215 and 28,353,215 and 25,724,844 shares issued and outstanding	2,843	2,836	2,572
Additional paid in capital	13,531,074	13,508,581	11,985,191
Accumulated deficit	(13,719,791)	(13,070,148)	(11,140,603)
TOTAL SHAREHOLDERS’ EQUITY	(185,874)	441,269	847,160
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 2,488,869	$ 2,851,186	$ 2,454,908

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	28,428,215	28,353,215	25,724,844
Common stock, shares outstanding	28,428,215	28,353,215	25,724,844

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Sales	$ 339,515	$ 2,137,607	$ 1,752,976
Cost of sales	112,238	760,955	1,278,469
Gross profit	227,277	1,376,652	474,507
Operating expenses
Consulting expense		592,659	1,005,655
Professional fees		171,024	218,760
Officer compensation		372,978	220,000
Payroll and related expense		939,061	827,343
General and administrative	873,503	663,119	286,795
Total operating expenses	873,503	2,738,841	2,558,553
Loss from operations	(646,226)	(1,362,189)	(2,084,046)
Other income (expense)
Interest expense	(3,417)	(11,001)	(45,860)
Other income		2,950
Change in value of derivative liability			(126,623)
Amortization of debt discount			(462,963)
Gain on forgiveness of debt		329,018
Equity loss in investment		(835,462)	(818,611)
Total other income (expense)	(3,417)	(514,495)	(1,454,057)
Loss before provision for income taxes	(649,643)	(1,876,684)	(3,538,103)
Provision for income taxes
Net loss	(649,643)	(1,876,684)	(3,538,103)
Deemed dividend for downround provision in warrants		(52,861)
Net loss attributed to common stockholders	$ (649,643)	$ (1,929,545)	$ (3,538,103)
Weighted average shares outstanding - basic and diluted (in Shares)	28,428,215	27,375,508	22,080,873
Loss per shares - basic and diluted (in Dollars per share)	$ (0.02)	$ (0.07)	$ (0.16)

Consolidated Statement of Chang

Consolidated Statement of Changes in Shareholders’ Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 2,007	$ 9,300,657	$ (7,602,500)	$ 1,700,164
Balance (in Shares) at Dec. 31, 2019	20,067,371
Issuance of common stock for services	$ 161	1,005,495		1,005,656
Issuance of common stock for services (in Shares)	1,606,111
Issuance of common stock for conversion of convertible debenture and accrued interest	$ 318	532,494		532,812
Issuance of common stock for conversion of convertible debenture and accrued interest (in Shares)	3,192,466
Issuance of common stock for investment	$ 86	601,141		601,227
Issuance of common stock for investment (in Shares)	858,896
Derivative liability resolution		545,404		545,404
Net loss			(3,538,103)	(3,538,103)
Balance at Dec. 31, 2020	$ 2,572	11,985,191	(11,140,603)	847,160
Balance (in Shares) at Dec. 31, 2020	25,724,844
Issuance of common stock for services	$ 126	737,262		737,388
Issuance of common stock for services (in Shares)	1,257,300
Issuance of common stock for conversion of convertible debenture and accrued interest	$ 25	99,975		100,000
Issuance of common stock for conversion of convertible debenture and accrued interest (in Shares)	250,000
Issuance of common stock for investment	$ 112	633,293		633,405
Issuance of common stock for investment (in Shares)	1,121,071
Deemed dividend for downround provision in warrants		52,861	(52,861)
Net loss			(1,876,684)	(1,876,684)
Balance at Dec. 31, 2021	$ 2,835	13,508,582	(13,070,148)	441,269
Balance (in Shares) at Dec. 31, 2021	28,353,215
Issuance of common stock for services	$ 8	22,492		22,500
Issuance of common stock for services (in Shares)	75,000
Net loss			(649,643)	(649,643)
Balance at Mar. 31, 2022	$ 2,843	$ 13,531,074	$ (13,719,791)	$ (185,874)
Balance (in Shares) at Mar. 31, 2022	28,428,215

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES
Net loss	$ (649,643)	$ (1,876,684)	$ (3,538,103)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,659	2,571	2,004
Adjustment to acquisition contingency			718
Bad debt expense		11,000
Issuance of common stock for services	62,526	673,617	1,005,656
Expenses paid directly by majority shareholder		87,410	40,000
Operating lease expense		55,079	156,720
Amortization of debt discounts			462,963
Forgiveness of PPP Loan		(329,018)
Change in value of derivative liability			126,623
Equity loss in investment		835,462	818,611
Changes in operating assets and liabilities:
Accounts receivable	82,541	80,625	305,101
Inventories	58,971	(474,625)	(219,437)
Prepaid expenses and other current assets	(713)		(1,000)
Accounts payable	(29,224)	30,882	(5,828)
Accounts payable - related parties	42,000	128,500
Accrued liabilities	51,610	322,203	20,345
Accrued compensation - officers	45,000	160,000	180,000
Customer deposits	(15,591)	(92,969)	188,198
Operating lease liability		(55,079)	(156,720)
Net cash used in operating activities	(338,864)	(441,026)	(614,149)
INVESTING ACTIVITIES
Purchase of property and equipment	(12,629)	(6,446)
Payment of acquisition deposit		(15,000)
Cash paid for investment			(235,000)
Net cash used in investing activities	(12,629)	(21,446)	(235,000)
FINANCING ACTIVITIES
Net borrowings (repayments) under lines of credit	(2,662)	119,600	(6,123)
Proceeds from sale of common stock		100,000
Proceeds from issuance of note payable		221,431	107,587
Repayments for note payable	(5,307)	(4,546)	(16,470)
Proceeds from note payable to shareholder	179,000	608,010	520,600
Repayments for note payable to shareholder		(563,010)	(616,801)
Net cash provided by (used in) financing activities	171,031	481,485	(11,207)
NET INCREASE (DECREASE) IN CASH	(180,462)	19,013	(860,356)
CASH
Beginning of period	246,317	227,304	1,087,660
End of period	65,855	246,317	227,304
Supplemental disclosures of cash flow information
Taxes paid
Interest paid	3,417	11,001	16,993
Non-Cash investing and financing activities
Reclassification of acquisition contingency to accounts payable			11,312
Common shares issued for future services		135,859
Deemed dividend on down round provision		52,861
Common stock issued for conversion of convertible debenture and accrued interest			532,812
Common stock issued for services
Common stock issued for investment			601,227
Relief of derivative liability			$ 545,404

Organization and Basis of Prese

Organization and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Organization and Basis of Presentation	Note 1 - Organization and Basis of Presentation Organization and Line of Business US Nuclear Corp., formerly known as APEX 3, Inc., (the “Company” or “US Nuclear”) was incorporated under the laws of the State of Delaware on February 14, 2012. On May 31, 2016, the Company entered into an Asset Purchase Agreement with Electronic Control Concepts (“ECC”) whereby the Company purchased certain tangible and intangible assets of ECC. The Company is engaged in developing, manufacturing and selling radiation detection and measuring equipment. The Company markets and sells its products to consumers throughout the world. Basis of Presentation The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company recorded a net loss of $649,643 for the three months ended March 31, 2022 and had an accumulated deficit of $13,719,791 as of March 31, 2022. The Company recorded a net loss of $1,876,684 for the year ended December 31, 2021 and had an accumulated deficit of $13,070,148 as of December 31, 2021, which raises substantial doubt about its ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Cali From Above, LLC, and Optron and its wholly-owned subsidiary, Overhoff Technology Corporation (“Overhoff”), and have been prepared in conformity with accounting principles generally accepted in the United States of America. All significant intercompany transactions and balances have been eliminated. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. There were no cash equivalents as of the three months ended March 31, 2022 and the years ending December 31, 2021 and 2020. Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company places its cash with high quality financial institutions and at times may exceed the FDIC insurance limit. The Company has not and does not anticipate incurring any losses related to this credit risk. Accounts Receivable The Company maintains reserves for potential credit losses for accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded based on the Company’s historical collection history. Allowance for doubtful accounts as of the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 were $16,000, $16,000, and $5,000, respectively. Inventories Inventories are valued at the lower of cost (determined primarily by the average cost method) or net realizable value. Management compares the cost of inventories with the net realizable value and allowance is made for writing down their inventories to net realizable value, if lower. As of the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020, there was no allowance for slow moving or obsolete inventory. The Company periodically assessed its inventory for slow moving and/or obsolete items. If any are identified an appropriate allowance for those items is made and/or the items are deemed to be impaired. Property and Equipment Property and Equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of equipment is provided using the straight-line method for substantially all assets with estimated lives as follows: Furniture and fixtures 5 years Leasehold improvement Lesser of lease life or economic life Equipment 5 years Computers and software 5 years Long-Lived Assets The Company applies the provisions of Accounting Standards Codification (“ASC”) Topic 360, Property, Plant, and Equipment Goodwill Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. The entire goodwill balance in the accompanying financial statements resulted from the Company’s acquisition of Overhoff Technology Corporation in 2006. The Company complies with ASC 350, Goodwill and Other Indefinite Lived Intangible Assets Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. During the year ended December 31, 2020, the convertible note payable was fully converted into shares of common stock; therefore, there was no derivative liability at December 31, 2020. During the three months ended March 31, 2022 and the year ended December 31, 2021, there was no derivative liability. Investments The Company accounts for investments in equity securities without a readily determinable fair value at cost, minus impairment. If the Company identifies observable price changes in orderly transactions for the identical or a similar investment of the same issuer, the Company measures the equity security at fair value as of the date that the observable transaction occurred (“the measurement alternative”) in accordance with ASC 321. The Company accounts for investments for which it owns 20% or more, but less than 50% on the equity method in accordance with ASC 323. Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, accrued liabilities, customer deposits, and line of credit, the carrying amounts approximate their fair values due to their short maturities. In addition, the Company has a note payable to shareholder that the carrying amount also approximates fair value. Revenue Recognition Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Topic 606 Topic 606. Topic 605, Revenue Recognition Revenue from the product sales are recognized under Topic 606 ● executed contracts with the Company’s customers that it believes are legally enforceable; ● identification of performance obligations in the respective contract; ● determination of the transaction price for each performance obligation in the respective contract; ● allocation the transaction price to each performance obligation; and ● recognition of revenue only when the Company satisfies each performance obligation. These five elements, as applied to each of the Company’s revenue category, is summarized below: ● Product sales - revenue is recognized when the Company performs its obligations under the contracts it has with its customers to deliver products at an agreed upon price and it is generally when the control of the product has been transferred to the customer. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as customer deposits. Sales returns and allowances was $0 for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020. The Company provides a one-year warranty on all sales. Warranty expense for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 was insignificant. The Company does not provide unconditional right of return, price protection or any other concessions to its customers. See Notes 11 and 12 for disclosures of revenue disaggregated by geographical area and product line. Customer Deposits Customer deposits represent cash paid to the Company by customers before the product has been completed and shipped. Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements. Stock-Based Compensation The Company records stock-based compensation in accordance with FASB ASC Topic 718,” Compensation – Stock Compensation Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share Segment Reporting FASB ASC Topic 280, Segment Reporting Related Parties The Company accounts for related party transactions in accordance with ASC 850, Related Party Disclosures Reclassifications Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity. Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes Income Taxes In January 2017, the FASB issued ASU 2017-04, Intangibles Goodwill and Other (Topic 350) Simplifying the Test for Goodwill Impairment Intangibles - Goodwill and Other In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity

Inventories

Inventories	3 Months Ended
	Mar. 31, 2022
Disclosure of Inventories [Abstract]
Inventories	Note 3 – Inventories Inventory at March 31, 2022 and December 31, 2021 and 2020 consisted of the following: 2022 2021 2020 Raw materials $ 723,444 $ 972,759 $ 924,313 Work in Progress 351,802 157,024 71,177 Finished goods 658,095 662,529 322,197 Total inventories $ 1,733,341 $ 1,792,312 $ 1,317,687 At December 31, 2021 and 2020 the inventory reserve was $0.

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 4 – Property and Equipment The following are the details of property and equipment at December 31, 2021 and 2020: 2022 2021 2020 Furniture and fixtures $ 148,033 $ 148,033 $ 148,033 Leasehold Improvements 50,091 50,091 50,091 Equipment 250,047 237,418 237,418 Computers and software 39,482 39,482 33,036 487,653 475,024 468,578 Less accumulated depreciation (478,964 ) (465,305 ) (462,734 ) Property and equipment, net $ 8,689 $ 9,719 $ 5,844 Depreciation expense for the three months ended March 31, 2-22 and for the years ended December 31, 2021 and 2020 was $1,030, $2,571 and $2,004, respectively. At March 31, 2022, December 31, 2021 and 2020, the Company had $440,628 of fully depreciated property and equipment that is still in use.

Investments

Investments	3 Months Ended
	Mar. 31, 2022
Investments [Abstract]
Investments	Note 5 – Investments MIFTEC On August 3, 2018, the Company closed an agreement by and among, MIFTEC Laboratories, Inc. (“MIFTEC”), a licensee of Magneto-Inertial Fusion Technologies, Inc., (“MIFTI”), and the Company. MIFTEC is a licensee of MIFTI radionuclide technology. MIFTEC will engage the Company to manufacture equipment pursuant to MIFTEC’s specifications and designs and have the Company as a sales representative for the manufactured equipment. The Company will be the exclusive manufacturer and supplier to MIFTEC of equipment in North America and Asia. In addition, the Company received a 10% ownership interest in MIFTEC. The consideration for the exclusive manufacturing rights and a 10% ownership interest in MIFTEC was $500,000 and 300,000 shares of the Company’s common stock valued at $594,000. The fair value was determined based on the Company’s stock price on August 3, 2018. The Company recorded the value of the 10% interest in MIFTEC at $10,000 and recorded $1,084,000 as the acquisition of manufacturing and supply rights in the accompanying consolidated statement of operations during the year ended December 31, 2018. The Company evaluated this investment for impairment and determined that an impairment of $9,000 was necessary during the year ended December 31, 2019. The carrying value of this investment at March 31, 2022, December 31, 2021 and 2020 was $1,000, $1,000, and $1,000, respectively. MIFTI In April 2019, the Company also entered into a Cooperative Agreement with MIFTI whereby the Company acquired certain exclusive manufacturing and supply rights, including thermonuclear fusion-powered reactor for production of electricity per MIFTI designs in return for $500,000, of which $100,000 is payable upon signing, $200,000 within four months of the agreement and $200,000 within nine months of the agreement. The $500,000 is an option to buy a 10% interest in MIFTI for $2,700,000, if completed with 24 months of the agreement date. If the options expires, MIFTI shall issue the Company 500,000 shares of common stock and rescind all other exclusive rights contained in the agreement. The option was rescinded and the Company received 500,000 shares of MIFTI common stock which represents an ownership of approximately 0.56% for its $500,000 investment. The Company evaluated this investment for impairment and determined that an impairment of $499,000 was necessary during the year ended December 31, 2019. The carrying value of this investment at March 31, 2022, December 31, 2021 and 2020 was $1,000, $1,000, and $1,000, respectively. Grapheton On February 5, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Grapheton, Inc., a California corporation (“Grapheton”). The transaction was closed on March 12, 2020. Grapheton is a start-up company that focuses on building energy storage devises, known as supercapacitors, from a new material system. The technology utilized by Grapheton has been proven to provide a compelling advantage in microelectrode arrays with superior electrical and electrochemical properties. Pursuant to the terms of the SPA, the Corporation will acquire a total of 2,552 shares of Grapheton’s common stock over a two year period. At closing, the Company was issued at total of 1,452 shares of Grapheton’s common stock for $235,000 and 858,896 shares of the Company’s common stock valued at $601,227. In connection with the SPA, during the second quarter of 2021 the Company received an additional 1,100 shares of Grapheton’s common stock in exchange for the Company’s issuing an additional 1,121,071 shares of common stock valued at $633,405. In addition, Grapheton fulfilled its requirements under the earn out provision and the Company is obligated to make the first earn out payment of $192,500. This amount is recorded as accrued expense in the accompanying consolidated balance sheet. An additional “true up” issuance of the Company’s common stock to Grapheton may be made on the second anniversary of the closing of the SPA, based on the valuation of the Company’s common stock on that date by a third-party valuator. The Company currently owns 35.8% of Grapheton and accounts for its investment in Grapheton using the equity method of accounting is accordance with ASC 323. Information regarding Grapheton as of and for the three months ended March 31, 2022 is below: Current assets $ 55,801 Total assets 64.156 Current liabilities 3,017 Total liabilities - Total stockholders’ equity $ 61,140 Revenue $ - Operating expenses (57,689 ) Other expenses - Net loss $ 57,689 Information regarding Grapheton as of and for the year ended December 31, 2021 is below: Current assets $ 110,472 Total assets 117,288 Current liabilities 11,052 Total liabilities 11,052 Total stockholders’ equity $ 106,236 Revenue $ 5,000 Operating expenses (59,811 ) Other expenses - Net loss $ 58,893 The Company evaluated this investment and recorded a loss attributed to equity investment of $835,462 during the year ended December 31, 2021. The carrying value of this investment at December 31, 2021 was $10,059.

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Notes Payable	Note 6 – Notes Payable In connection with the acquisition of assets from ECC the Company issued a note payable to the owner of ECC. The note accrued interest at 5% per annum, requires quarterly principal and interest payments of $4,518 and is due on April 15, 2021. At March 31, 2022, December 31, 2021, and 2020, the amount outstanding under this note payable was $20,619, $48,541. and 9,818, respectively. The Company was in default on payment of the note payable as of December 31, 2021. The Company has communicated with the debt holder, and the amount is considered payable on demand as of March 31, 2022. In June 2020 the Company received a loan under the Paycheck Protection Program of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act for $107,587. The loan has terms of 24 months and accrues interest at 1% per annum. In February of 2021, the Company received two additional loans totaling $221,431 under the Paycheck Protection Program of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. As of December 31, 2021, The Company has had these loans forgiven in the amount of $329,018 as provided by the CARES Act. On December 26, 2020, a line of credit held by the company had matured, and based on the terms of the line of credit agreement was converted to a note payable upon demand. As of the date of the conversion, the amount owed by the Company was $43,269. Future maturities of notes payable as of March 31, 2022 are as follows: Years Ending December 31, 2021 $ 20,619 2022 - 2023 - 2024 - 2025 - Thereafter - $ 20,619 Future maturities of notes payable as of December 31, 2021 are as follows: Years Ending December 31, 2021 $ 48,541 2022 - 2023 - 2024 - 2025 - Thereafter - $ 48,541

Note Payable to Shareholder

Note Payable to Shareholder	3 Months Ended
	Mar. 31, 2022
Note Payable To Shareholder [Abstract]
Note Payable to Shareholder	Note 7 – Note Payable to Shareholder Robert Goldstein, the CEO and majority shareholder, has loaned funds to the Company from time to time to cover general operating expenses. These loans are evidenced by unsecured, non-interest-bearing notes due on December 31, 2022. During the year ended December 31, 2020, the Company’s majority shareholder paid expenses on behalf of the Company of $40,000, loaned an additional $520,600 to the Company and was repaid $616,801. During the year ended December 31, 2021, the Company’s majority shareholder paid expenses on behalf of the Company of $87,410 and loaned an additional $45,000 to the Company. During the three months ended March 31, 2022, the Company’s majority shareholder paid expenses on behalf of the Company of $0 and loaned an additional $179,000 to the Company. The amounts due to Mr. Goldstein are $755,260, $576,260 and $443,850 as of March 31, 2022 and December 31, 2021 and 2020, respectively.

Line of Credit

Line of Credit	3 Months Ended
	Mar. 31, 2022
Line of Credit Facility [Abstract]
Line of Credit	Note 8 – Line of Credit As of March 31, 2022, the Company had four lines of credit with a maximum borrowing amount of $400,000 with interest ranging from 5.5% to 11.5%. As of March 31, 2022, December 31, 2021 and 2020, the amounts outstanding under these lines of credit were $305,427, $285,474 and $209,143, respectively.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Note 9 – Leases The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate which is based on the interest rate of similar debt outstanding. The Company leases its current facilities from Gold Team Inc., a company owned by the Company’s CEO, which owns both the Canoga Park, CA and Milford, Ohio locations. The leases expired on April 30, 2020 and the Company exercised its renewal option for an additional 12 months. The new lease is not more than 12 months; therefore, the disclosures under ASC 842 are not required. Future minimum lease payments under this agreement for the twelve months ending December 31, 2022 is $98,000. Effective January 1, 2019, the Company adopted the provision of ASC 842 Leases. The table below presents the lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of December 31, 2021 and 2020: Classification on Balance Sheet 2021 2020 Assets Operating lease assets Operating lease right of use assets $ - $ 55,079 Total lease assets $ - $ 55,079 Liabilities Current liabilities Operating lease liability Current operating lease liability $ - $ 55,079 Noncurrent liabilities Operating lease liability Long-term operating lease liability - 55,079 Total lease liability $ - $ 55,079 Lease obligations at December 31, 2021 consisted of the following: Years Ending December 31, 2021 Total payments $ - Amount representing interest - Lease obligation, net - Less lease obligation, current portion - Lease obligation, long-term portion - $ - The lease expense for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 was $42,000, $168,000 and $168,000, respectively. The cash paid under operating leases during the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 was $0, $42,000, and $168,000, respectively. At December 31, 2021, $126,000 was accrued and is shown on the balance sheet as accounts payable- related party. At December 31, 2021, the weighted average remaining lease terms were 0.3 years and the weighted average discount rate was 8%

Shareholders_ Equity

Shareholders’ Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholders’ Equity	Note 10 – Shareholders’ Equity Common stock During the three months ended March 31, 2022, the Company issued: ● 75,000 shares of common stock to consultants for services rendered valued at $22,500. The fair value was determined based on the Company’s stock price on the grant date. During the year ended December 31, 2021, the Company issued: ● 1,252,300 shares of common stock to consultants for services rendered valued at $737,388. The fair value was determined based on the Company’s stock price on the grant date. Pursuant to ASC 718 the company has allocated a portion of stock-based compensation to prepaid expenses until the services are provided to the Company. The amount allocated to prepaid expense at December 31, 2021 is $40,026. ● 1,121,071 shares of common stock for an investment in Grapheton valued at $633,405. The fair value was determined based on the Company’s stock price on the grant date. ● 250,000 shares of common stock for cash proceeds of $100,000 During the year ended December 31, 2020, the Company issued: ● 1,606,111 shares of common stock to consultants for services rendered valued at $1,005,656. The fair value was determined based on the Company’s stock price on the grant date; ● 3,192,466 shares of common stock for convertible notes and accrued interest of $500,000 and $32,812, respectively; and ● 858,896 shares of common stock for an investment in Grapheton valued at $601,227. The fair value was determined based on the Company’s stock price on the grant date. Warrants The following table summarizes the activity related to warrants: Weighted Weighted Average Average Remaining Aggregate Warrants Exercise Contractual Intrinsic Outstanding Price Life Value Outstanding, December 31, 2020 333,333 $ 0.40 1.50 $ - Granted - Forfeited - Exercised - Outstanding, December 31, 2021 333,333 $ 0.36 0.90 $ - Granted - Forfeited - Exercised - Outstanding, March 31, 2022 333,333 $ 0.30 0.65 $ 6,667 Exercisable, March 31, 2022 333,333 $ 0.30 0.65 $ 6,667 The above warrants contain a down round provision that requires the exercise price to be adjusted if the Company sells shares of common stock below the current exercise price. During the twelve months ended December 31, 2021, the Company issued shares of common stock for $0.36 therefore, the exercise price of these warrants was adjusted from $1.50 to $0.36. The change in fair value between the value of the warrants using the new exercise price versus the old exercise price was calculated to be $52,861. This amount is recorded as a deemed dividend in the accompanying consolidated financial statements during the year ended December 31, 2021. The above warrants also contains a down round provision that requires the exercise price to be adjusted if the Company sells shares of common stock below the current exercise price. During the three months ended March 31, 2022, the Company issued shares of common stock for $0.30 therefore, the exercise price of these warrants was adjusted from $0.36 to $0.30. The change in fair value between the value of the warrants using the new exercise price versus the old exercise price was calculated to be $9,950. This amount is recorded as a deemed dividend in the accompanying consolidated financial statements during the three months ended March 31, 2022 The following table summarizes information about options outstanding and exercisable as of March 31, 2022 Outstanding and Exercisable Number of Warrants Exercise Price 333,333 $ 0.36 333,333

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Reporting	Note 11 – Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company has two reportable segments: Optron and Overhoff. Optron is located in Canoga Park, California and Overhoff is located in Milford, Ohio. The assets and operations of the Company’s recent acquisition of the assets of Electronic Control Concepts are included with Overhoff in the table below. The assets and operations of the Company’s newest subsidiary, Cali From Above are included with Optron in the table below. The following tables summarize the Company’s segment information for the years ended December 31, 2021 and 2020: Years Ended December 31, 2021 2020 Sales Optron $ 482,582 $ 554,890 Overhoff 1,655,025 1,198,086 Corporate - - $ 2,137,607 $ 1,752,976 Gross profit Optron $ 101,447 $ 124,673 Overhoff 1,275,205 349,834 Corporate - - $ 1,376,652 $ 474,507 Income (loss) from operations Optron $ (799,837 ) $ (684,097 ) Overhoff 264,763 (86,862 ) Corporate (1,757,739 ) (1,313,087 ) $ (1,876,684 ) $ (2,084,046 ) Interest Expenses Optron $ 10,076 $ 15,615 Overhoff - - Corporate 925 30,245 $ 11,001 $ 45,860 Net income (loss) Optron $ (799,837 ) $ (675,712 ) Overhoff 520,939 (122,862 ) Corporate (1,757,739 ) (2,739,529 ) $ (1,876,684 ) $ (3,538,103 ) As of December 31, 2021 2020 Total Assets Optron $ 1,027,669 $ 1,084,440 Overhoff 1,754,485 1,320,197 Corporate 69,032 50,271 $ 2,851,186 $ 2,454,908 Goodwill Optron $ - $ - Overhoff 570,176 570,176 Corporate - - $ 570,176 $ 570,176 The following tables summarize the Company’s segment information for the three months ended March 31, 2022 and 2021: Three Months Ended 2022 2021 Sales Optron $ 56,994 $ 22,816 Overhoff 282,521 395,008 Corporate - - $ 339,515 $ 417,824 Gross profit Optron $ 44,082 $ 13,424 Overhoff 183,195 187,748 Corporate - - $ 227,277 $ 201,172 Income (loss) from operations Optron $ (218,838 ) $ (194,493 ) Overhoff (306,356 ) (22,655 ) Corporate (121,036 ) (441,831 ) $ (646,226 ) $ (658,979 ) Interest Expenses Optron $ 2,445 $ 2,823 Overhoff 972 - Corporate - - $ 3,417 $ 2,823 Net income (loss) Optron $ (215,283 ) $ (191,316 ) Overhoff (316,324 ) (28,655 ) Corporate (118,036 ) (443,590 ) $ (649,643 ) $ (663,561 ) As of As of Total Assets 2022 2021 Optron $ 1,056,154 $ 1,027,669 Overhoff 1,403,675 1,754,485 Corporate 29,040 69,032 $ 2, $ 2,851,186 Goodwill Optron $ - $ - Overhoff 570,176 570,176 Corporate - - $ 570,176 $ 570,176

Geographical Sales

Geographical Sales	3 Months Ended
	Mar. 31, 2022
Geographical Sales [Abstract]
Geographical Sales	Note 12 - Geographical Sales The geographical distribution of the Company’s sales for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 is as follows: Three Years Ended 2022 2021 2020 Geographical sales North America $ 305,490 $ 1,522,412 $ 1,348,228 Asia 14,403 473,157 349,499 South America 15,501 4,932 - Other 4,121 137,106 55,249 $ 339,515 $ 2,137,607 $ 1,752,976

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 13 – Income Taxes At December 31, 2021 and 2020, the significant components of the deferred tax assets are summarized below: 2021 2020 Approximate net operating loss carry forwards $ 10,605,000 $ 8,724,000 Deferred tax assets: Federal net operating loss $ 2,226,947 $ 1,832,139 State net operating loss 723,270 591,976 Tax credit 49,740 49,740 Goodwill (148,373 ) (148,373 ) Total deferred tax assets 2,226,947 2,325,482 Less valuation allowance (2,226,947 ) (2,325,482 ) $ - $ - The valuation allowance increased by $526,103 and $590,433 in 2021 and 2020 due to the Company generating additional net operating losses. The Company’s remaining tax credit carryforwards of $49,740 begin to expire in 2027 and its net operating loss carryforward of approximately $10,605,000 begin to expire in 2028. Income tax expense reflected in the consolidated statements of income consist of the following for 2021 and 2020: 2021 2020 Current Federal $ - $ - State - - - - Deferred Federal - - State - - - - Income tax expense $ - $ - The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2021 and 2020 is as follows: 2021 2020 Federal income tax rate 21.0 % 21.0 % State tax, net of federal benefit 6.0 % 6.0 % Net operating losses -16.7 % -16.7 % Permanent differences -10.6 % -10.6 % Amortization of goodwill 0.3 % 0.3 % Effective income tax rate 0.0 % 0.0 % The Company files income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations by tax authorities for years before 2015. The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors. Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations. There were no interest or penalties accrued as of December 31, 2021 and 2020.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 14 – Related Party Transactions The Company leases its current facilities from Gold Team Inc., a company owned by the Company’s CEO, which owns both the Canoga Park, CA and Milford, Ohio locations. Rent expense for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 were $42,000, $168,000, and $168,000, respectively. As of March 31, 2022, December 31, 2021, and 2020, payable to Gold Team Inc. in connection with the above leases amount to $210,000, $126,000, and $0, respectively. ( See Note 9 During the year ended, December 31, 2021, the company issued 242,823 shares of common stock to Richard Landry in connection with the consulting services agreement entered by and between US Nuclear Corp and Richard Landry. As of December 31, 2021, the company has accrued accounting fees owed to Rachel Boulds, the Company’s previous Chief Financial Officer, in the amount of $2,500 for fourth quarter services performed. In addition, as of March 31, 2022, December 31, 2021 and 2020, the Company had accrued compensation payable to its majority shareholder of $475,000, $450,000, and $350,000, respectively. Also see Note 10

Concentrations

Concentrations	3 Months Ended
	Mar. 31, 2022
Risks and Uncertainties [Abstract]
Concentrations	Note 15 - Concentrations One customer accounted for 45.8% of the Company’s sales for the three months ended March 31, 2022 and one customer accounted for 61.4% of the Company’s sales for the three months ended March 31, 2021. No vendors accounted for more than 10% of the Company’s purchases for the three months ended March 31, 2022 and 2021. Two customers accounted for more than 10% of the Company sales for the year ended December 31, 2021, 30.7% and 15.2%, respectively. and at December 31, 2021 two customers accounted for more than 10% of the accounts receivable balance, 23.9% and 15%, respectively. One customer accounted for 46.9% of the Company sales for the year ended December 31, 2020 and at December 31, 2020 one customer accounted for 75.2% of the accounts receivable balance. No vendors accounted for more than 10% of the Company’s purchases for the years ended December 31, 2021 and 2020.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 16 – Subsequent Events Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were available to be issued and has determined that no material subsequent events exist other than the following: ● Subsequent to December 31, 2021, the Company issued 75,000 shares of common stock for consulting services. On May 5, 2022, the Company issued a note payable to a third party in the principal sum of $750,000, in exchange for consideration of $675,000. The note will be receiving interest of 5% per year, with the maturity date being 12 months from the issue date. Any amounts that are unpaid principal will continue to have interest of no less than 16% as default rate. The note is convertible at a price of $0.20 per share, subject to adjustment as needed. In addition to this issuance, the company issued 625,000 shares of common stock and warrants to purchase up to an additional 1,500,000 shares of common stock, exercisable at $0.75 per share, with an exercise period of three years from the date of issuance. Subsequent to March 31, 2022, the Company issued 240,000 shares of common stock for investor relation services. Subsequent to March 31, 2022, the Company issued 120,805 shares of common stock for broker services. On June 30, 2022, Rachel Boulds, Chief Financial Officer, resigned her position with the Company. Richard Landry was appointed as Chief Financial Officer of the Company on the same day as Ms. Bould’s resignation, with the same salary he has received as Chief Operating Officer.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Cali From Above, LLC, and Optron and its wholly-owned subsidiary, Overhoff Technology Corporation (“Overhoff”), and have been prepared in conformity with accounting principles generally accepted in the United States of America. All significant intercompany transactions and balances have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash on hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. There were no cash equivalents as of the three months ended March 31, 2022 and the years ending December 31, 2021 and 2020.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents. The Company places its cash with high quality financial institutions and at times may exceed the FDIC insurance limit. The Company has not and does not anticipate incurring any losses related to this credit risk.
Accounts Receivable	Accounts Receivable The Company maintains reserves for potential credit losses for accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded based on the Company’s historical collection history. Allowance for doubtful accounts as of the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 were $16,000, $16,000, and $5,000, respectively.
Inventories	Inventories Inventories are valued at the lower of cost (determined primarily by the average cost method) or net realizable value. Management compares the cost of inventories with the net realizable value and allowance is made for writing down their inventories to net realizable value, if lower. As of the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020, there was no allowance for slow moving or obsolete inventory. The Company periodically assessed its inventory for slow moving and/or obsolete items. If any are identified an appropriate allowance for those items is made and/or the items are deemed to be impaired.
Property and Equipment	Property and Equipment Property and Equipment are stated at cost. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of equipment is provided using the straight-line method for substantially all assets with estimated lives as follows:
Long-Lived Assets	Long-Lived Assets The Company applies the provisions of Accounting Standards Codification (“ASC”) Topic 360, Property, Plant, and Equipment
Goodwill	Goodwill Goodwill represents the excess of purchase price over the underlying net assets of businesses acquired. The entire goodwill balance in the accompanying financial statements resulted from the Company’s acquisition of Overhoff Technology Corporation in 2006. The Company complies with ASC 350, Goodwill and Other Indefinite Lived Intangible Assets
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. During the year ended December 31, 2020, the convertible note payable was fully converted into shares of common stock; therefore, there was no derivative liability at December 31, 2020. During the three months ended March 31, 2022 and the year ended December 31, 2021, there was no derivative liability.
Investments	Investments The Company accounts for investments in equity securities without a readily determinable fair value at cost, minus impairment. If the Company identifies observable price changes in orderly transactions for the identical or a similar investment of the same issuer, the Company measures the equity security at fair value as of the date that the observable transaction occurred (“the measurement alternative”) in accordance with ASC 321. The Company accounts for investments for which it owns 20% or more, but less than 50% on the equity method in accordance with ASC 323.
Fair Value of Financial Instruments	Fair Value of Financial Instruments For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, accrued liabilities, customer deposits, and line of credit, the carrying amounts approximate their fair values due to their short maturities. In addition, the Company has a note payable to shareholder that the carrying amount also approximates fair value.
Revenue Recognition	Revenue Recognition Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers Topic 606 Topic 606. Topic 605, Revenue Recognition Revenue from the product sales are recognized under Topic 606 ● executed contracts with the Company’s customers that it believes are legally enforceable; ● identification of performance obligations in the respective contract; ● determination of the transaction price for each performance obligation in the respective contract; ● allocation the transaction price to each performance obligation; and ● recognition of revenue only when the Company satisfies each performance obligation. These five elements, as applied to each of the Company’s revenue category, is summarized below: ● Product sales - revenue is recognized when the Company performs its obligations under the contracts it has with its customers to deliver products at an agreed upon price and it is generally when the control of the product has been transferred to the customer. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as customer deposits. Sales returns and allowances was $0 for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020. The Company provides a one-year warranty on all sales. Warranty expense for the three months ended March 31, 2022 and the years ended December 31, 2021 and 2020 was insignificant. The Company does not provide unconditional right of return, price protection or any other concessions to its customers. See Notes 11 and 12 for disclosures of revenue disaggregated by geographical area and product line.
Customer Deposits	Customer Deposits Customer deposits represent cash paid to the Company by customers before the product has been completed and shipped.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption had no effect on the Company’s consolidated financial statements.
Stock-Based Compensation	Stock-Based Compensation The Company records stock-based compensation in accordance with FASB ASC Topic 718,” Compensation – Stock Compensation
Basic and Diluted Earnings Per Share	Basic and Diluted Earnings Per Share Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share
Segment Reporting	Segment Reporting FASB ASC Topic 280, Segment Reporting
Related Parties	Related Parties The Company accounts for related party transactions in accordance with ASC 850, Related Party Disclosures
Reclassifications	Reclassifications Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes Income Taxes In January 2017, the FASB issued ASU 2017-04, Intangibles Goodwill and Other (Topic 350) Simplifying the Test for Goodwill Impairment Intangibles - Goodwill and Other In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Schedule of estimated useful lives of property and equipment	Furniture and fixtures 5 years Leasehold improvement Lesser of lease life or economic life Equipment 5 years Computers and software 5 years

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2022
Inventories [Abstract]
Schedule of inventories	2022 2021 2020 Raw materials $ 723,444 $ 972,759 $ 924,313 Work in Progress 351,802 157,024 71,177 Finished goods 658,095 662,529 322,197 Total inventories $ 1,733,341 $ 1,792,312 $ 1,317,687

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	2022 2021 2020 Furniture and fixtures $ 148,033 $ 148,033 $ 148,033 Leasehold Improvements 50,091 50,091 50,091 Equipment 250,047 237,418 237,418 Computers and software 39,482 39,482 33,036 487,653 475,024 468,578 Less accumulated depreciation (478,964 ) (465,305 ) (462,734 ) Property and equipment, net $ 8,689 $ 9,719 $ 5,844

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2022
Investments [Abstract]
Schedule of information regarding grapeheton	Current assets $ 55,801 Total assets 64.156 Current liabilities 3,017 Total liabilities - Total stockholders’ equity $ 61,140 Revenue $ - Operating expenses (57,689 ) Other expenses - Net loss $ 57,689 Current assets $ 110,472 Total assets 117,288 Current liabilities 11,052 Total liabilities 11,052 Total stockholders’ equity $ 106,236 Revenue $ 5,000 Operating expenses (59,811 ) Other expenses - Net loss $ 58,893

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of future maturities of notes payable	Years Ending December 31, 2021 $ 20,619 2022 - 2023 - 2024 - 2025 - Thereafter - $ 20,619 Years Ending December 31, 2021 $ 48,541 2022 - 2023 - 2024 - 2025 - Thereafter - $ 48,541

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of lease obligations	Classification on Balance Sheet 2021 2020 Assets Operating lease assets Operating lease right of use assets $ - $ 55,079 Total lease assets $ - $ 55,079 Liabilities Current liabilities Operating lease liability Current operating lease liability $ - $ 55,079 Noncurrent liabilities Operating lease liability Long-term operating lease liability - 55,079 Total lease liability $ - $ 55,079
Schedule of lease obligations	Years Ending December 31, 2021 Total payments $ - Amount representing interest - Lease obligation, net - Less lease obligation, current portion - Lease obligation, long-term portion - $ -

Shareholders_ Equity (Tables)

Shareholders’ Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of activity related to warrants	● 75,000 shares of common stock to consultants for services rendered valued at $22,500. The fair value was determined based on the Company’s stock price on the grant date. Weighted Weighted Average Average Remaining Aggregate Warrants Exercise Contractual Intrinsic Outstanding Price Life Value Outstanding, December 31, 2020 333,333 $ 0.40 1.50 $ - Granted - Forfeited - Exercised - Outstanding, December 31, 2021 333,333 $ 0.36 0.90 $ - Granted - Forfeited - Exercised - Outstanding, March 31, 2022 333,333 $ 0.30 0.65 $ 6,667 Exercisable, March 31, 2022 333,333 $ 0.30 0.65 $ 6,667
Schedule of information about options outstanding and exercisable	Outstanding and Exercisable Number of Warrants Exercise Price 333,333 $ 0.36 333,333

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of company's segment reporting information	Years Ended December 31, 2021 2020 Sales Optron $ 482,582 $ 554,890 Overhoff 1,655,025 1,198,086 Corporate - - $ 2,137,607 $ 1,752,976 Gross profit Optron $ 101,447 $ 124,673 Overhoff 1,275,205 349,834 Corporate - - $ 1,376,652 $ 474,507 Income (loss) from operations Optron $ (799,837 ) $ (684,097 ) Overhoff 264,763 (86,862 ) Corporate (1,757,739 ) (1,313,087 ) $ (1,876,684 ) $ (2,084,046 ) Interest Expenses Optron $ 10,076 $ 15,615 Overhoff - - Corporate 925 30,245 $ 11,001 $ 45,860 Net income (loss) Optron $ (799,837 ) $ (675,712 ) Overhoff 520,939 (122,862 ) Corporate (1,757,739 ) (2,739,529 ) $ (1,876,684 ) $ (3,538,103 ) As of December 31, 2021 2020 Total Assets Optron $ 1,027,669 $ 1,084,440 Overhoff 1,754,485 1,320,197 Corporate 69,032 50,271 $ 2,851,186 $ 2,454,908 Goodwill Optron $ - $ - Overhoff 570,176 570,176 Corporate - - $ 570,176 $ 570,176 Three Months Ended 2022 2021 Sales Optron $ 56,994 $ 22,816 Overhoff 282,521 395,008 Corporate - - $ 339,515 $ 417,824 Gross profit Optron $ 44,082 $ 13,424 Overhoff 183,195 187,748 Corporate - - $ 227,277 $ 201,172 Income (loss) from operations Optron $ (218,838 ) $ (194,493 ) Overhoff (306,356 ) (22,655 ) Corporate (121,036 ) (441,831 ) $ (646,226 ) $ (658,979 ) Interest Expenses Optron $ 2,445 $ 2,823 Overhoff 972 - Corporate - - $ 3,417 $ 2,823 Net income (loss) Optron $ (215,283 ) $ (191,316 ) Overhoff (316,324 ) (28,655 ) Corporate (118,036 ) (443,590 ) $ (649,643 ) $ (663,561 ) As of As of Total Assets 2022 2021 Optron $ 1,056,154 $ 1,027,669 Overhoff 1,403,675 1,754,485 Corporate 29,040 69,032 $ 2, $ 2,851,186 Goodwill Optron $ - $ - Overhoff 570,176 570,176 Corporate - - $ 570,176 $ 570,176

Geographical Sales (Tables)

Geographical Sales (Tables)	3 Months Ended
	Mar. 31, 2022
Geographical Sales [Abstract]
Schedule of geographical distribution of company's sales	Three Years Ended 2022 2021 2020 Geographical sales North America $ 305,490 $ 1,522,412 $ 1,348,228 Asia 14,403 473,157 349,499 South America 15,501 4,932 - Other 4,121 137,106 55,249 $ 339,515 $ 2,137,607 $ 1,752,976

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets	2021 2020 Approximate net operating loss carry forwards $ 10,605,000 $ 8,724,000 Deferred tax assets: Federal net operating loss $ 2,226,947 $ 1,832,139 State net operating loss 723,270 591,976 Tax credit 49,740 49,740 Goodwill (148,373 ) (148,373 ) Total deferred tax assets 2,226,947 2,325,482 Less valuation allowance (2,226,947 ) (2,325,482 ) $ - $ -
Schedule of consolidated statements of income	2021 2020 Current Federal $ - $ - State - - - - Deferred Federal - - State - - - - Income tax expense $ - $ -
Schedule of income tax rate to the federal statutory rate	2021 2020 Federal income tax rate 21.0 % 21.0 % State tax, net of federal benefit 6.0 % 6.0 % Net operating losses -16.7 % -16.7 % Permanent differences -10.6 % -10.6 % Amortization of goodwill 0.3 % 0.3 % Effective income tax rate 0.0 % 0.0 %

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Net loss	$ 649,643	$ 1,876,684
Accumulated deficit	$ 13,719,791	$ (13,070,148)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Allowance for doubtful accounts	$ 16,000	$ 16,000	$ 5,000
Investments percentage	20%
Equity method percentage	50%
Sales returns and allowances	$ 0	$ 0	$ 0
Tax benefit, percentage	50%
Warrants outstanding (in Shares)	333,333	333,333	333,333

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment	3 Months Ended
	Mar. 31, 2022
Furniture and fixtures [Member]
Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	5 years
Leasehold Improvement [Member]
Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	Lesser of lease life or economic life
Equipment [Member]
Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	5 years
Computers and software [Member]
Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	5 years

Inventories (Details)

Inventories (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory reserve	$ 0	$ 0

Inventories (Details) - Schedul

Inventories (Details) - Schedule of inventories - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of inventories [Abstract]
Raw materials	$ 723,444	$ 972,759	$ 924,313
Work in Progress	351,802	157,024	71,177
Finished goods	658,095	662,529	322,197
Total inventories	$ 1,733,341	$ 1,792,312	$ 1,317,687

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,030	$ 2,571	$ 2,004
Depreciated property plant and equipment	$ 440,628	$ 440,628	$ 440,628

Property and Equipment (Detai_2

Property and Equipment (Details) - Schedule of property and equipment - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 487,653	$ 475,024	$ 468,578
Less accumulated depreciation	(478,964)	(465,305)	(462,734)
Property and equipment, net	8,689	9,719	5,844
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	148,033	148,033	148,033
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	50,091	50,091	50,091
Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	250,047	237,418	237,418
Computers and Software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 39,482	$ 39,482	$ 33,036

Investments (Details)

Investments (Details) - USD ($)		1 Months Ended	3 Months Ended	12 Months Ended
	Aug. 03, 2018	Apr. 30, 2019	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Investments (Details) [Line Items]
Ownership interest	10%
Ownership interest in MIFTEC			50%
Investment amount		$ 500,000
MIFTEC (in Shares)		500,000
Carrying value of investment			$ 1,000	$ 1,000	$ 1,000
Investment, description			Pursuant to the terms of the SPA, the Corporation will acquire a total of 2,552 shares of Grapheton’s common stock over a two year period. At closing, the Company was issued at total of 1,452 shares of Grapheton’s common stock for $235,000 and 858,896 shares of the Company’s common stock valued at $601,227.
Ownership interest in MIFTEC		0.56%
Exchange for common stock, shares (in Shares)			1,100
Out payment			$ 192,500
Ownership, percentage			35.80%
Equity investment				835,462
Investment Owned, at Cost				10,059
MIFTEC [Member]
Investments (Details) [Line Items]
Ownership interest in MIFTEC	10%
Investment amount	$ 500,000
MIFTEC (in Shares)	300,000
Common stock value	$ 594,000
Interest rate							10%
Interest in MIFTEC							$ 10,000
Acquisition of manufacturing and supply right							$ 1,084,000
Investment for impairment						$ 9,000
Carrying value of investment			$ 1,000	$ 1,000
MIFTEC [Member]
Investments (Details) [Line Items]
Investment for impairment						$ 499,000
Carrying value of investment					$ 1,000
Investment, description		the Company also entered into a Cooperative Agreement with MIFTI whereby the Company acquired certain exclusive manufacturing and supply rights, including thermonuclear fusion-powered reactor for production of electricity per MIFTI designs in return for $500,000, of which $100,000 is payable upon signing, $200,000 within four months of the agreement and $200,000 within nine months of the agreement. The $500,000 is an option to buy a 10% interest in MIFTI for $2,700,000, if completed with 24 months of the agreement date. If the options expires, MIFTI shall issue the Company 500,000 shares of common stock and rescind all other exclusive rights contained in the agreement.
Grapheton, Inc [Member]
Investments (Details) [Line Items]
Exchange for common stock, shares (in Shares)			1,121,071
Common stock value (in Shares)			633,405

Investments (Details) - Schedul

Investments (Details) - Schedule of information regarding grapeheton - Grapheton, Inc [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Investments (Details) - Schedule of information regarding grapeheton [Line Items]
Current assets	$ 55,801	$ 110,472
Total assets	64.156	117,288
Current liabilities	3,017	11,052
Total liabilities		11,052
Total stockholders’ equity	61,140	106,236
Revenue		5,000
Operating expenses	(57,689)	(59,811)
Other expenses
Net loss	$ 57,689	$ 58,893

Notes Payable (Details)

Notes Payable (Details) - USD ($)	1 Months Ended		3 Months Ended
	Dec. 26, 2020	Jun. 30, 2020	Mar. 31, 2022	Dec. 31, 2021	Feb. 28, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Interest rate			5%
Principal and interest payments			$ 4,518
Outstanding notes payable			$ 20,619	$ 48,541		$ 9,818
Loan amount		$ 107,587
Notes Payable, description			The loan has terms of 24 months and accrues interest at 1% per annum.
Total of additional loans					$ 221,431
Debt instrument face amount				$ 329,018
Owed amount	$ 43,269

Notes Payable (Details) - Sched

Notes Payable (Details) - Schedule of future maturities of notes payable - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Schedule of future maturities of notes payable [Abstract]
2021	$ 20,619	$ 48,541
2022
2023
2024
2025
Thereafter
Total	$ 20,619	$ 48,541

Note Payable to Shareholder (De

Note Payable to Shareholder (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Note Payable to Shareholder (Details) [Line Items]
Note payable, description	Robert Goldstein, the CEO and majority shareholder, has loaned funds to the Company from time to time to cover general operating expenses. These loans are evidenced by unsecured, non-interest-bearing notes due on December 31, 2022.
Shareholder paid expenses	$ 0	$ 87,410	$ 40,000
Majority shareholder loaned an additional	179,000	45,000	520,600
Repayments for note payable to shareholder			616,801
Mr. Goldstein [Member]
Note Payable to Shareholder (Details) [Line Items]
Amounts due	$ 755,260	$ 576,260	$ 443,850

Line of Credit (Details)

Line of Credit (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Line of Credit (Details) [Line Items]
Line of credit outstanding	$ 305,427	$ 285,474	$ 209,143
Line of Credit [Member]
Line of Credit (Details) [Line Items]
Line of credit maximum borrowing amount	$ 400,000
Line of Credit [Member] | Minimum [Member]
Line of Credit (Details) [Line Items]
Interest rate on line of credit	5.50%
Line of Credit [Member] | Maximum [Member]
Line of Credit (Details) [Line Items]
Interest rate on line of credit	11.50%

Leases (Details)

Leases (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases (Textual)
Lease term, description	The Company leases its current facilities from Gold Team Inc., a company owned by the Company’s CEO, which owns both the Canoga Park, CA and Milford, Ohio locations. The leases expired on April 30, 2020 and the Company exercised its renewal option for an additional 12 months. The new lease is not more than 12 months; therefore, the disclosures under ASC 842 are not required. Future minimum lease payments under this agreement for the twelve months ending December 31, 2022 is $98,000. Effective January 1, 2019, the Company adopted the provision of ASC 842 Leases.
Lease expense	$ 42,000	$ 168,000	$ 168,000
Operating leases payment	$ 0	42,000	$ 168,000
Accounts payable- related party		$ 126,000
Weighted average remaining lease terms		3 months 18 days
Weighted average discount rate		8%

Leases (Details) - Schedule of

Leases (Details) - Schedule of lease related assets and liabilities - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Assets
Operating lease assets			$ 55,079
Total lease assets			55,079
Current liabilities
Operating lease liability			55,079
Noncurrent liabilities
Operating lease liability			55,079
Total lease liability			$ 55,079

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of lease obligations	12 Months Ended
	Dec. 31, 2021 USD ($)
Schedule of lease obligations [Abstract]
Total payments
Amount representing interest
Lease obligation, net
Less lease obligation, current portion
Lease obligation, long-term portion
Total

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Shareholders’ Equity (Details) [Line Items]
Prepaid expense		$ 40,026
Shares of common stock issued (in Shares)		250,000
Cash proceeds		$ 100,000
Shares issued for convertible notes (in Shares)			3,192,466
Convertible notes			$ 500,000
Accrued interest			$ 32,812
Common stock per share (in Dollars per share)	$ 0.3	$ 0.36
Warrants exercise price Increase (in Dollars per share)	0.36	1.5
Warrant exercise price decrease (in Dollars per share)	$ 0.3	$ 0.36
Exercise price	$ 9,950	$ 52,861
Common stock, description	●75,000 shares of common stock to consultants for services rendered valued at $22,500. The fair value was determined based on the Company’s stock price on the grant date.
Grapheton [Member]
Shareholders’ Equity (Details) [Line Items]
Shares of common stock issued (in Shares)		1,121,071	858,896
Investment value		$ 633,405	$ 601,227
Consultants [Member]
Shareholders’ Equity (Details) [Line Items]
Common stock issued for services, shares (in Shares)		1,252,300	1,606,111
Common stock issued for services		$ 737,388	$ 1,005,656

Shareholders_ Equity (Details)

Shareholders’ Equity (Details) - Schedule of activity related to warrants - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Schedule of activity related to warrants [Abstract]
Warrants Outstanding, at beginning	333,333	333,333
Weighted Average Exercise Price, at beginning (in Dollars per share)	$ 0.36	$ 0.4
Weighted Average Remaining Contractual Life, at beginning		1 year 6 months
Aggregate Intrinsic Value, at beginning (in Dollars)
Warrants Outstanding, Granted
Warrants Outstanding, Forfeited
Warrants Outstanding, Exercised
Warrants Outstanding, at ending	333,333	333,333
Weighted Average Exercise Price, at ending (in Dollars per share)	$ 0.3	$ 0.36
Weighted Average Remaining Contractual Life, at ending	7 months 24 days	10 months 24 days
Aggregate Intrinsic Value, at ending (in Dollars)	$ 6,667
Warrants Outstanding, Exercisable	333,333
Warrants Outstanding, Exercisable (in Dollars per share)	$ 0.3
Weighted Average Remaining Contractual Life, Exercisable	7 months 24 days
Aggregate Intrinsic Value, Exercisable (in Dollars)	$ 6,667

Shareholders_ Equity (Details_2

Shareholders’ Equity (Details) - Schedule of information about options outstanding and exercisable - Warrant [Member]	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Warrants	333,333
Exercise Price (in Dollars per share) | $ / shares	$ 0.36
Number of Warrants	333,333

Segment Reporting (Details)

Segment Reporting (Details)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Reporting (Details) - S

Segment Reporting (Details) - Schedule of company's segment reporting information - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Sales
Sales	$ 339,515	$ 417,824	$ 2,137,607	$ 1,752,976
Gross profit
Gross profit	227,277	201,172	1,376,652	474,507
Income (loss) from operations
Income (loss) from operations	(646,226)	(658,979)	(1,876,684)	(2,084,046)
Interest Expenses
Interest Expenses	3,417	2,823	11,001	45,860
Net income (loss)
Net income (loss)	(649,643)	(663,561)	(1,876,684)	(3,538,103)
Total Assets
Total Assets	2		2,851,186	2,454,908
Goodwill
Goodwill	570,176		570,176	570,176
Operating Segments [Member] | Optron [Member]
Gross profit
Gross profit	44,082	13,424
Income (loss) from operations
Income (loss) from operations	(218,838)	(194,493)
Interest Expenses
Interest Expenses	2,445	2,823
Net income (loss)
Net income (loss)	(215,283)	(191,316)
Total Assets
Total Assets	1,056,154		1,027,669
Goodwill
Goodwill
Operating Segments [Member] | Overhoff [Member]
Gross profit
Gross profit	183,195	187,748
Income (loss) from operations
Income (loss) from operations	(306,356)	(22,655)
Interest Expenses
Interest Expenses	972
Net income (loss)
Net income (loss)	(316,324)	(28,655)
Total Assets
Total Assets	1,403,675		1,754,485
Goodwill
Goodwill	570,176		570,176
Operating Segments [Member] | Corporate [Member]
Sales
Sales
Gross profit
Gross profit
Income (loss) from operations
Income (loss) from operations	(121,036)	(441,831)
Interest Expenses
Interest Expenses
Net income (loss)
Net income (loss)	(118,036)	(443,590)
Total Assets
Total Assets	29,040		69,032
Goodwill
Goodwill
Operating Segments [Member] | Optron [Member]
Sales
Sales	56,994	22,816	482,582	554,890
Gross profit
Gross profit			101,447	124,673
Income (loss) from operations
Income (loss) from operations			(799,837)	(684,097)
Interest Expenses
Interest Expenses			10,076	15,615
Net income (loss)
Net income (loss)			(799,837)	(675,712)
Total Assets
Total Assets			1,027,669	1,084,440
Goodwill
Goodwill
Operating Segments [Member] | Overhoff [Member]
Sales
Sales	$ 282,521	$ 395,008	1,655,025	1,198,086
Gross profit
Gross profit			1,275,205	349,834
Income (loss) from operations
Income (loss) from operations			264,763	(86,862)
Interest Expenses
Interest Expenses
Net income (loss)
Net income (loss)			520,939	(122,862)
Total Assets
Total Assets			1,754,485	1,320,197
Goodwill
Goodwill			570,176	570,176
Operating Segments [Member] | Corporate [Member]
Sales
Sales
Gross profit
Gross profit
Income (loss) from operations
Income (loss) from operations			(1,757,739)	(1,313,087)
Interest Expenses
Interest Expenses			925	30,245
Net income (loss)
Net income (loss)			(1,757,739)	(2,739,529)
Total Assets
Total Assets			69,032	50,271
Goodwill
Goodwill

Geographical Sales (Details) -

Geographical Sales (Details) - Schedule of geographical distribution of company's sales - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Geographical Sales (Details) - Schedule of geographical distribution of company's sales [Line Items]
Geographical sales	$ 339,515	$ 2,137,607	$ 1,752,976
North America [Member]
Geographical Sales (Details) - Schedule of geographical distribution of company's sales [Line Items]
Geographical sales	305,490	1,522,412	1,348,228
Asia [Member]
Geographical Sales (Details) - Schedule of geographical distribution of company's sales [Line Items]
Geographical sales	14,403	473,157	349,499
South America [Member]
Geographical Sales (Details) - Schedule of geographical distribution of company's sales [Line Items]
Geographical sales	15,501	4,932
Other [Member]
Geographical Sales (Details) - Schedule of geographical distribution of company's sales [Line Items]
Geographical sales	$ 4,121	$ 137,106	$ 55,249

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes (Details) [Line Items]
Valuation allowance		$ 526,103	$ 590,433
Expire year	2028
Net operating loss carryforward	$ 10,605,000
Investment Tax Credit Carryforward [Member]
Income Taxes (Details) [Line Items]
Tax credit carryforward	$ 49,740
Expire year	2027

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of deferred tax assets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of deferred tax assets [Abstract]
Approximate net operating loss carry forwards	$ 10,605,000	$ 8,724,000
Deferred tax assets:
Federal net operating loss	2,226,947	1,832,139
State net operating loss	723,270	591,976
Tax credit	49,740	49,740
Goodwill	(148,373)	(148,373)
Total deferred tax assets	2,226,947	2,325,482
Less valuation allowance	(2,226,947)	(2,325,482)
Total

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of consolidated statements of income - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Current
Federal
State
Total
Deferred
Federal
State
Total
Income tax expense

Income Taxes (Details) - Sche_3

Income Taxes (Details) - Schedule of income tax rate to the federal statutory rate	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of income tax rate to the federal statutory rate [Abstract]
Federal income tax rate	21%	21%
State tax, net of federal benefit	6%	6%
Net operating losses	(16.70%)	(16.70%)
Permanent differences	(10.60%)	(10.60%)
Amortization of goodwill	0.30%	0.30%
Effective income tax rate	0%	0%

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions (Details) [Line Items]
Accounting fees		$ 2,500
Accrued compensation payable	$ 475,000	$ 450,000	$ 350,000
Richard Landry [Member]
Related Party Transactions (Details) [Line Items]
Shares issued (in Shares)		242,823
Gold Team Inc. [Member]
Related Party Transactions (Details) [Line Items]
Rent expense	42,000	$ 168,000	168,000
Payable to related party	$ 210,000	$ 126,000	$ 0

Concentrations (Details)

Concentrations (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Customer 1 [Member]
Concentrations (Details) [Line Items]
Concentration percentage	45.80%
Sales [Member]
Concentrations (Details) [Line Items]
Concentration percentage			10%
Sales [Member] | Customer 1 [Member]
Concentrations (Details) [Line Items]
Concentration percentage		61.40%	30.70%	46.90%
Sales [Member] | Customer 2 [Member]
Concentrations (Details) [Line Items]
Concentration percentage			15.20%
Purchase [Member] | Vendor [Member]
Concentrations (Details) [Line Items]
Concentration Risk, Description	No vendors accounted for more than 10% of the Company’s purchases for the three months ended March 31, 2022 and 2021.		No vendors accounted for more than 10% of the Company’s purchases for the years ended December 31, 2021 and 2020.
Accounts Receivable [Member]
Concentrations (Details) [Line Items]
Concentration percentage			10%
Accounts Receivable [Member] | Customer 1 [Member]
Concentrations (Details) [Line Items]
Concentration percentage			23.90%	75.20%
Accounts Receivable [Member] | Customer 2 [Member]
Concentrations (Details) [Line Items]
Concentration percentage			15%

Subsequent Events (Details)

Subsequent Events (Details) - shares	May 05, 2022	Mar. 31, 2022	Dec. 31, 2021
Common Stock [Member]
Subsequent Events (Details) [Line Items]
Shares of common stock			75,000
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Note payable description	the Company issued a note payable to a third party in the principal sum of $750,000, in exchange for consideration of $675,000. The note will be receiving interest of 5% per year, with the maturity date being 12 months from the issue date. Any amounts that are unpaid principal will continue to have interest of no less than 16% as default rate. The note is convertible at a price of $0.20 per share, subject to adjustment as needed. In addition to this issuance, the company issued 625,000 shares of common stock and warrants to purchase up to an additional 1,500,000 shares of common stock, exercisable at $0.75 per share, with an exercise period of three years from the date of issuance.
Investor Relation Services [Member]
Subsequent Events (Details) [Line Items]
Common stock for services		240,000
Broker Services [Member]
Subsequent Events (Details) [Line Items]
Common stock for services		120,805